Skip to main content
logo
Lytix Biopharma ASA (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
8.28
+0.02 (0.24%)
Oct 2, 2026, 4:25 PM CET

Lytix Biopharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
637674401195311533
Market Cap Growth
29.55%68.03%106.12%-37.37%-41.63%-
Enterprise Value
547587361116139323
Last Close Price
8.289.835.854.847.7213.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--36.0548.7928.1927.59
PB Ratio
7.3510.923.723.802.302.81
P/TBV Ratio
7.3510.923.723.802.302.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--32.3929.0612.6316.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.040.020.010.010.01
Net Debt / Equity Ratio
-1.03-1.14-1.19-0.97-1.06-1.03
Net Debt / EBITDA Ratio
0.911.101.340.522.194.11
Net Debt / FCF Ratio
1.031.171.820.522.734.37
Asset Turnover
--0.110.040.060.16
Quick Ratio
7.604.233.905.018.5114.29
Current Ratio
7.604.283.915.068.5514.33
Return on Equity (ROE)
-107.13%-70.71%-118.41%-94.33%-34.54%-45.90%
Return on Assets (ROA)
-58.83%-35.09%-56.97%-55.72%-22.90%-25.23%
Return on Capital Employed (ROCE)
-113.40%-101.70%-87.40%-188.40%-48.50%-25.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.86%-8.89%-23.48%-45.14%-18.03%-9.03%
FCF Yield
-13.66%-8.87%-17.53%-49.31%-16.98%-8.37%
Buyback Yield / Dilution
-6.99%-26.05%-35.05%-1.01%-19.50%-26.57%